Adding a T-cell receptor to CAR T cells may reduce side effects of immunotherapies designed to target solid tumors.
All tagged cancer
Adding a T-cell receptor to CAR T cells may reduce side effects of immunotherapies designed to target solid tumors.
U of U Health scientists open the door to clinical advances by examining the ways disease impacts the body, molecule by molecule.
Aberrant RAS proteins, found in 20 to 30 percent of cancers, can promote the export of proteins from a cell’s nucleus to its cytoplasm, where some can contribute to cancerous growth.
Waves of regulatory changes can transform self-renewing neuroblastoma cells into neurons.
Immune cells convert an immunosuppressive lipid into an anticancer immunity enhancer.
NCI trial leads to first drug approval for a very rare cancer.
March 2024. Full story at National Cancer Institute.
Studies identify a marker of treatment response for patients with advanced, drug-resistant ovarian cancer.
Full story at National Cancer Institute.
Studying osteosarcoma in dogs may improve treatment options for people and pets.
A new view of cell division changes scientists’ thinking about how some cancer drugs impact cells.